Skip to main content
$5.64 -$0.18 (-3.1%)

04:00 PM EST on 01/21/22

Cel-sci Corp (NYSEMKT:CVM)

CAPS Rating: 1 out of 5

The Company engages in the research and development of drugs and vaccines. Its most advanced product, Multikine, manufactured using the Company's proprietary cell culture technologies, is being developed for the treatment of cancer.

Current Price $5.64 Mkt Cap $243.9M
Open $5.80 P/E Ratio 0.00
Prev. Close $5.64 Div. (Yield) $0.00 (0.0%)
Daily Range $5.63 - $6.13 Volume 1,193,725
52-Wk Range $5.63 - $40.91 Avg. Daily Vol. 987,216

Caps

How do you think NYSEMKT:CVM will perform against the market?

Add Stock to CAPS Watchlist

All Players

95 Outperform
36 Underperform
 

All-Star Players

5 Outperform
16 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSEMKT:CVM Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

rosepicker (< 20)
Submitted April 23, 2020

This company is about to have the FDA approve their cure for cancer.

zzlangerhans (99.37)
Submitted June 05, 2016

Has it really been over a year since I looked at Cel-Sci? I knew my life was missing something. Catching up was very entertaining. Things are as scuzzy and futile as ever over at Cel-Sci.Last February I pointed out that the company's claim of being… More

NYSEMKT:CVM VS S&P 500 (SPY)

Fools bullish on NYSEMKT:CVM are also bullish on:

Fools bearish on NYSEMKT:CVM are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about CVM.

Recs

0
Member Avatar TMFSecurity (90.74) Submitted: 11/16/2021 10:05:04 AM : Underperform Start Price: $11.75 NYSE MKT:CVM Score: +44.60

10000000146

Recs

1
Member Avatar rosepicker (< 20) Submitted: 4/23/2020 12:29:15 AM : Outperform Start Price: $10.83 NYSE MKT:CVM Score: -71.33

This company is about to have the FDA approve their cure for cancer.

Recs

1
Member Avatar lightrock (< 20) Submitted: 9/21/2019 6:06:14 PM : Outperform Start Price: $8.50 NYSE MKT:CVM Score: -79.78

I've studied the statistic on this from public information for a long time, the odds are highly in favor of a successful clinical trial with staggering consequences.

Leaderboard

Find the members with the highest scoring picks in CVM.

Score Leader

dexxyru

dexxyru (< 20) Score: +416.96

The Score Leader is the player with the highest score across all their picks in CVM.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
dexxyru < 20 9/24/2009 Underperform 5Y $397.50 -98.55% +318.42% +416.96 0 Comment
bermuda999 40.65 8/16/2010 Underperform 1Y $125.25 -95.39% +308.77% +404.15 0 Comment
DarthMaul09 28.50 10/16/2009 Underperform 5Y $387.50 -98.51% +304.15% +402.65 4 Comments
pennycruncher < 20 10/19/2009 Underperform 5Y $380.00 -98.48% +303.14% +401.62 0 Comment
arboretum 29.53 6/14/2010 Underperform 5Y $125.00 -95.38% +297.86% +393.23 0 Comment
qasamm 21.48 1/3/2011 Underperform 3M $209.88 -97.25% +247.02% +344.27 0 Comment
Rollme < 20 10/8/2013 Underperform 5Y $21.48 -73.08% +164.53% +237.62 0 Comment
remrem44 39.40 3/14/2014 Underperform 3Y $34.17 -83.08% +137.33% +220.42 0 Comment
kinosternon 97.56 2/28/2014 9/21/2018 Underperform 1Y $28.18 -79.49% +135.10% +214.59 0 Comment
MMCapitalMgmt 99.96 1/21/2014 Underperform 5Y $22.88 -74.73% +138.84% +213.58 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for CVM.